ArticleDigestive diseases and sciences2026
Outcomes of Endoscopic Ultrasound-Guided Gallbladder Drainage Using Lumen-Apposing Metal Stent Performed by Early Career Advanced Endoscopists: A Multicenter Study.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsEndoscopic ultrasound-guided gallbladder drainage (EUS-GBD) has gained popularity for acute cholecystitis (AC) management in patients deemed unfit for surgery. Recent studies have found > 95% technical success and > 90% clinical success when performed by experienced advanced endoscopists. Recently, the U.S. Food and Drug Administration (FDA) approved the use of lumen-apposing metal stent (LAMS) for EUS-GBD. The aim of this study is to evaluate the safety and efficacy of EUS-GBD performed by early-career advanced endoscopists in North America.
methodsThis was a retrospective multicenter study of patients who underwent EUS-GBD performed by 8 early-career advanced endoscopists (defined as within 3 years of graduation from advanced endoscopy fellowship (AEF)) between January 2021 and March 2024. Primary outcomes included technical success (ability to place LAMS into the gallbladder) and clinical success (resolution of symptoms and laboratory abnormalities). Secondary outcomes included adverse events (AEs) and 30-day readmission rates.
resultsA total of 57 patients (mean age 70.7 years, 59.6% male) were included. The most common site of EUS-GBD was the duodenum (57.9%) and LAMS size 10 × 10 mm (71.9%). The technical success rate was 98.2%, and the clinical success rate was 98.2%. AEs occurred in 3.5% (n = 2), including gallbladder perforation and recurrent AC following stent migration. The 30-day readmission rate was 5.3% (n = 3). There was no procedure-related mortality.
conclusionsOur study demonstrates that EUS-GBD is safe and effective when performed by early-career advanced endoscopists. These outcomes are similar to previous data when performed by experienced advanced endoscopists.
Indexed as
Identifiers
41152606What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.